<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">Much has been made in public health of the value of cost-effectiveness analyses, and indeed they can de-politicize issues. Although cost-effectiveness is a very important criterion, it is not the only one for hepatitis C treatment programmes, even with forecasts of cure rates of up to 95% within 12Â weeks. Indeed, budget impact analysis and immediate availability of funds and resources are the keys to initiate sustainable programmes. The social costs besides medical costs need much better quantification.</p>
